Reduced risk of back pain following teriparatide treatment: a meta-analysis
Michael C. Nevitt(University of California, San Francisco), John H. Krege(Eli Lilly (United States)), José Zanchetta(Universidad del Salvador), Robin K. Dore(University of California, Los Angeles), Jean‐Yves Reginster(King Saud University), Emmett V. Glass(Eli Lilly (United States)), Peiqi Chen(Eli Lilly (United States)), Douglas P. Kiel(Harvard University)
Cited by 132
Related Papers
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.4k
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
|Osteoporosis International|2012|2.9k
The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates
|The Journals of Gerontology Series A|2014|2.5k
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
|Osteoporosis International|2018|1.8k
Generation and reproductive phenotypes of mice lacking estrogen receptor β
|Proceedings of the National Academy of Sciences|1998|1.7k